Company profile
Swedish Orphan Biovitrum company profile
Swedish Orphan Biovitrum engages in the development, marketing, and distribution of orphan products and specialty pharmaceuticals. It offers drugs for the treatment of rare and life-threatening diseases, such as cardiology, diseases affecting immunocompromised patients, genetic disorders, haematology, infectious diseases, metabolic disorders, oncology, palliative care, poison control, respiratory diseases, and urology.
Business identity
- Website
- http://www.sobi.com/en
- Contact email
- [email protected]
- Phone number
- (468)697-2000
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1,001-5,000 employees
- Revenue range
- $100M-$1B
- Founded
- 1988-01-01, Year
Headquarters
- Headquarters
- Solna, Stockholm, Sweden
- Postal code
- 112 76
- Country code
- SE
- Continent
- Europe